NTEC Intec Pharma Ltd.

0.77
+0.03  (+4%)
Previous Close 0.74
Open 0.75
Price To Book 0.73
Market Cap 25,643,156
Shares 35,019,479
Volume 508,007
Short Ratio
Av. Daily Volume 2,259,646
Stock charts supplied by TradingView

NewsSee all news

  1. Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society

    JERUSALEM, Sept. 25, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces that two posters highlighting data from the Company's Phase 3 clinical development

  2. Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society

    JERUSALEM, Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces that two posters in support of the Company's Phase 3 clinical development program

  3. Intec Pharma to Participate in September Investment Conferences

    JERUSALEM, Sept. 3, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming

  4. Thinking about buying stock in Aurora Cannabis, Lannett, Intec Pharma, Tilray, or Yelp?

    NEW YORK, Aug. 28, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, LCI, NTEC, TLRY, and YELP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 3 data released July 22, 2019 did not meet primary endpoint.
AP-CDLD
Advanced Parkinson's Disease

Latest News

  1. Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society

    JERUSALEM, Sept. 25, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces that two posters highlighting data from the Company's Phase 3 clinical development

  2. Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society

    JERUSALEM, Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces that two posters in support of the Company's Phase 3 clinical development program

  3. Intec Pharma to Participate in September Investment Conferences

    JERUSALEM, Sept. 3, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ:NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming

  4. Thinking about buying stock in Aurora Cannabis, Lannett, Intec Pharma, Tilray, or Yelp?

    NEW YORK, Aug. 28, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, LCI, NTEC, TLRY, and YELP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the